Titre : Lectine liant le mannose

Lectine liant le mannose : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Lectine liant le mannose : Questions médicales les plus fréquentes", "headline": "Lectine liant le mannose : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Lectine liant le mannose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-15", "dateModified": "2025-02-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Lectine liant le mannose" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Lectines liant le mannose", "url": "https://recherchemedicale.com/mesh/D037241", "about": { "@type": "MedicalCondition", "name": "Lectines liant le mannose", "code": { "@type": "MedicalCode", "code": "D037241", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.503.311" } } }, "about": { "@type": "MedicalCondition", "name": "Lectine liant le mannose", "alternateName": "Mannose-Binding Lectin", "code": { "@type": "MedicalCode", "code": "D037601", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jatinder Singh", "url": "https://recherchemedicale.com/author/Jatinder%20Singh", "affiliation": { "@type": "Organization", "name": "Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, India." } }, { "@type": "Person", "name": "Manpreet Kaur", "url": "https://recherchemedicale.com/author/Manpreet%20Kaur", "affiliation": { "@type": "Organization", "name": "Department of Human Genetics, Guru Nanak Dev University, Amritsar, India." } }, { "@type": "Person", "name": "Namarta Kalia", "url": "https://recherchemedicale.com/author/Namarta%20Kalia", "affiliation": { "@type": "Organization", "name": "Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, India." } }, { "@type": "Person", "name": "Kárita Cláudia Freitas Lidani", "url": "https://recherchemedicale.com/author/K%C3%A1rita%20Cl%C3%A1udia%20Freitas%20Lidani", "affiliation": { "@type": "Organization", "name": "Laboratory of Molecular Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Brazil." } }, { "@type": "Person", "name": "Fabiana Antunes Andrade", "url": "https://recherchemedicale.com/author/Fabiana%20Antunes%20Andrade", "affiliation": { "@type": "Organization", "name": "Laboratory of Molecular Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Serum mannan-binding lectin-associated serine proteases in early pregnancy for gestational diabetes in Chinese pregnant women.", "datePublished": "2023-10-24", "url": "https://recherchemedicale.com/article/37941903", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1230244" } }, { "@type": "ScholarlyArticle", "name": "A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients.", "datePublished": "2023-06-16", "url": "https://recherchemedicale.com/article/37398656", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2023.1191083" } }, { "@type": "ScholarlyArticle", "name": "Synergy of protease-binding sites within the ecotin homodimer is crucial for inhibition of MASP enzymes and for blocking lectin pathway activation.", "datePublished": "2022-04-25", "url": "https://recherchemedicale.com/article/35483450", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jbc.2022.101985" } }, { "@type": "ScholarlyArticle", "name": "Rapid Detection of Gram-Positive and -Negative Bacteria in Water Samples Using Mannan-Binding Lectin-Based Visual Biosensor.", "datePublished": "2022-03-15", "url": "https://recherchemedicale.com/article/35290028", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acssensors.1c01748" } }, { "@type": "ScholarlyArticle", "name": "A solution structure analysis reveals a bent collagen triple helix in the complement activation recognition molecule mannan-binding lectin.", "datePublished": "2022-12-15", "url": "https://recherchemedicale.com/article/36528062", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jbc.2022.102799" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Recherchemedicale.com", "item": "https://recherchemedicale.com" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://recherchemedicale.com/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://recherchemedicale.com/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Lectines", "item": "https://recherchemedicale.com/mesh/D037102" }, { "@type": "ListItem", "position": 5, "name": "Lectines liant le mannose", "item": "https://recherchemedicale.com/mesh/D037241" }, { "@type": "ListItem", "position": 6, "name": "Lectine liant le mannose", "item": "https://recherchemedicale.com/mesh/D037601" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Lectine liant le mannose - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Lectine liant le mannose", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-02-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Lectine liant le mannose", "description": "Comment diagnostiquer une déficience en lectine liant le mannose ?\nQuels tests sont utilisés pour évaluer la fonction immunitaire ?\nQuels symptômes peuvent indiquer un problème avec la lectine ?\nLa génétique joue-t-elle un rôle dans le diagnostic ?\nPeut-on utiliser des biomarqueurs pour le diagnostic ?", "url": "https://recherchemedicale.com/mesh/D037601?page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Lectine liant le mannose", "description": "Quels sont les symptômes d'une déficience en lectine liant le mannose ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes cutanés associés ?\nLes symptômes sont-ils similaires à d'autres maladies ?\nComment les symptômes évoluent-ils avec le temps ?", "url": "https://recherchemedicale.com/mesh/D037601?page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Lectine liant le mannose", "description": "Comment prévenir les infections chez les patients déficients ?\nLes changements de mode de vie aident-ils à la prévention ?\nLes vaccinations sont-elles recommandées ?\nFaut-il éviter certains environnements ?\nDes suppléments nutritionnels sont-ils bénéfiques ?", "url": "https://recherchemedicale.com/mesh/D037601?page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Lectine liant le mannose", "description": "Quels traitements sont disponibles pour la déficience en lectine ?\nLa thérapie génique est-elle une option ?\nComment gérer les infections récurrentes ?\nLes traitements sont-ils personnalisés ?\nY a-t-il des effets secondaires aux traitements ?", "url": "https://recherchemedicale.com/mesh/D037601?page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Lectine liant le mannose", "description": "Quelles complications peuvent survenir avec une déficience en lectine ?\nLes infections peuvent-elles entraîner des hospitalisations ?\nY a-t-il un risque accru de cancer ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?", "url": "https://recherchemedicale.com/mesh/D037601?page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Lectine liant le mannose", "description": "Quels sont les facteurs de risque pour la déficience en lectine ?\nLes maladies auto-immunes augmentent-elles le risque ?\nLe sexe influence-t-il le risque ?\nL'environnement joue-t-il un rôle ?\nLes habitudes de vie affectent-elles le risque ?", "url": "https://recherchemedicale.com/mesh/D037601?page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en lectine liant le mannose ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test sanguin peut mesurer les niveaux de lectine liant le mannose." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la fonction immunitaire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'immunoglobulines et des tests de complément peuvent être effectués." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec la lectine ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Infections récurrentes et inflammation peuvent signaler un dysfonctionnement." } }, { "@type": "Question", "name": "La génétique joue-t-elle un rôle dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests génétiques peuvent identifier des mutations liées à la déficience." } }, { "@type": "Question", "name": "Peut-on utiliser des biomarqueurs pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des biomarqueurs spécifiques peuvent aider à évaluer l'activité de la lectine." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en lectine liant le mannose ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Infections fréquentes, fatigue, et inflammation chronique sont courants." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent présenter des infections plus sévères que les adultes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées peuvent survenir en raison d'infections récurrentes." } }, { "@type": "Question", "name": "Les symptômes sont-ils similaires à d'autres maladies ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent ressembler à ceux des autres déficiences immunitaires." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent s'aggraver sans traitement approprié, entraînant des complications." } }, { "@type": "Question", "name": "Comment prévenir les infections chez les patients déficients ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hygiène, des vaccinations et un suivi médical régulier sont essentiels." } }, { "@type": "Question", "name": "Les changements de mode de vie aident-ils à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée et l'exercice renforcent le système immunitaire." } }, { "@type": "Question", "name": "Les vaccinations sont-elles recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent aider à prévenir certaines infections graves." } }, { "@type": "Question", "name": "Faut-il éviter certains environnements ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter les foules et les personnes malades peut réduire le risque d'infection." } }, { "@type": "Question", "name": "Des suppléments nutritionnels sont-ils bénéfiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments comme la vitamine C peuvent soutenir le système immunitaire." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la déficience en lectine ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des antibiotiques et des immunoglobulines intraveineuses." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore largement disponible." } }, { "@type": "Question", "name": "Comment gérer les infections récurrentes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une prophylaxie antibiotique peut être recommandée pour prévenir les infections." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés selon la gravité et les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des réactions allergiques peuvent survenir." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une déficience en lectine ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des infections graves, des maladies auto-immunes et des complications pulmonaires." } }, { "@type": "Question", "name": "Les infections peuvent-elles entraîner des hospitalisations ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections sévères peuvent nécessiter une hospitalisation prolongée." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un risque accru de cancers chez les patients déficients." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et des tests peuvent aider à détecter les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour la déficience en lectine ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, certaines maladies génétiques et l'âge avancé." } }, { "@type": "Question", "name": "Les maladies auto-immunes augmentent-elles le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies auto-immunes peuvent être associées à une déficience en lectine." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études montrent que le risque peut être plus élevé chez les hommes." } }, { "@type": "Question", "name": "L'environnement joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des environnements avec une forte exposition aux infections augmentent le risque." } }, { "@type": "Question", "name": "Les habitudes de vie affectent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme et une mauvaise alimentation peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Serum mannan-binding lectin-associated serine proteases in early pregnancy for gestational diabetes in Chinese pregnant women.

This study aimed to explore associations of mannan-binding lectin-associated serine protease (MASP) levels in early pregnancy with gestational diabetes mellitus (GDM). We also examined interactions of... A 1:1 case-control study (n = 414) nested in a prospective cohort of pregnant women was conducted in Tianjin, China. Binary conditional logistic regressions were performed to examine associations of M... High MASP-2 was independently associated with GDM [odds ratio (OR): 2.62, 95% confidence interval (CI): 1.44-4.77], while the effect of high MASP-1 on GDM was attributable to high MASP-2 (... High MASP-1 and MASP-2 in early pregnancy were associated with GDM in Chinese pregnant women. MASP-2 amplifies the risk of low DCA for GDM, which is mediated via LPC18:0....

Synergy of protease-binding sites within the ecotin homodimer is crucial for inhibition of MASP enzymes and for blocking lectin pathway activation.

Ecotin is a homodimeric serine protease inhibitor produced by many commensal and pathogenic microbes. It functions as a virulence factor, enabling survival of various pathogens in the blood. The ecoti...

Role of cytokines, chemokines, C3a, and mannose-binding lectin in the evolution of the chikungunya infection.

The pathogenesis of the severity of chikungunya infection is not yet fully understood.... To assess the role of the cytokines/chemokines and system of complement in the evolution of chikungunya infection.... In both acute and chronic phases, we measured the serum levels of 12 cytokines/chemokines and two complement mediators: mannose-binding lectin (MBL) and C3a, in 83 patients with chikungunya infection ... During the acute phase, 75.9% of the patients developed musculoskeletal disorders, and in 37.7% of them, these disorders persisted until the chronic phase. In general, patients had higher levels of cy... Our results showed an immunological response that persisted until the chronic phase and the role of the complement system in the severity of the disease....

Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy.

Hematopoietic stem-cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) is a serious complication with significant mortality and no approved therapy. HSCT-TMA results from endothelial... In this single-arm open-label pivotal trial (NCT02222545), patients received intravenous narsoplimab once weekly for 4-8 weeks. The primary end point (response rate) required clinical improvement in t... The response rate was 61% in the FAS population. Similar responses were observed across all patient subgroups defined by baseline features, HSCT characteristics, and HSCT complications. Improvement in... In this study, narsoplimab treatment was safe, significantly improved laboratory TMA markers, and resulted in clinical response and favorable overall survival....